Strategies to establish a biologically defined Parkinson's disease cohort prior to the onset of clinically significant motor symptoms
Identifying individuals at risk for neurodegeneration is a priority for clinical trials. Parkinson's Precision Medicine Initiative (PPMI) deploys strategies to enroll individuals before typical…